Cancer Resources

Laryngeal cancer falls under the umbrella term of head and neck cancers and is the second commonest cancer type within this group. The condition often presents with symptoms shared with those of other less serious diseases, making diagnosis challenging.
This article hopes to give nurses and non-medical prescribers an overview of symptoms, diagnosis, treatment, and prognosis with the aim of raising awareness and helping to get an earlier diagnosis of this devastating disease.

The importance of early diagnosis in cancer is better understood today than it has ever been. Spotting cancer in its earliest stages offers better treatment options and improved survival (Cancer Research UK, 2024). This is particularly stark for bowel cancer,
where more than nine in 10 people survive when diagnosed at stage 1, dropping dramatically to less than one in 10 at stage 4.

Rectal cancer is a common diagnosis which is often treated by surgical resection of the cancer. However, cancer treatment can result in changes in bowel function. Faecal incontinence can occur because of cancer treatment, as well as increased defecation. Although these symptoms will improve with time over a few months, making changes, such as dietary ones with nursing support, can help. Having a greater understanding of issues that can occur and ways in which to resolve them can improve both healthcare professional confidence and circumstances for patients with bowel dysfunction.

Early diagnosis of bowel cancer is key to saving lives. It is the UK’s second biggest cancer killer with more than 16,500 deaths from the disease every year — one every 30 minutes (Cancer Research UK, 2022a). Yet, it is treatable and curable if detected early. Almost everyone diagnosed at stage I will survive bowel cancer, but sadly early diagnosis has remained stubbornly low with less than 40% of diagnoses at stages I and II (Cancer Research UK, 2022b).

Bowel Cancer UK is the UK’s leading bowel cancer charity, determined to save lives and improve the quality of life of everyone affected by bowel cancer. Its vision is a future where nobody dies of the disease. Bowel cancer is the fourth most common cancer in the UK and the second biggest cancer killer (Bowel Cancer UK, 2022a). Nearly 43,000
people are diagnosed with bowel cancer every year in the UK (Bowel Cancer UK, 2022b).

Cancer survival rates are increasing, resulting in more people living with treatment or disease-related side-effects. Cancer is now considered to be a long-term condition and patients can present with a wide range of physical, psychological and social needs. Community nurses often see people living with or after cancer, but are not always recognised as part of the cancer workforce. This article outlines a pilot of a ‘cancer in the community’ four-day teaching module for community nurses in South West London. The conclusion and recommendations make the case for community nurses to receive education on cancer as a long-term condition and highlight key learning points from the pilot.

Social care has become a hot topic in the news in the past year, with the worries and fears of the sector being widely reported. Many people may think it is an issue which does not affect them — but the reality is that most of us at some point in our lives will need care and support.

There are currently approximately 2.5 million people in the UK living with, or recovering from, cancer and it is further estimated that 1.8 million of these people will have at least one other longterm health condition. Community nurses have a responsibility to promote health at every opportunity when supporting those living with, and recovering from, cancer. The cancer care review is one aspect of the patient’s recovery package, which aims to help them recover from cancer and its treatment and identifies their individual concerns and support needs. The benefit of the recovery package is that it enables patients completing cancer treatment to take more control of their own care. In trying to help patients to improve their own health they will need support to think about devising an action plan should new concerns or symptoms arise. This article examines how a recovery package can, through assessment and monitoring, help to identify potential problems as well as offering preemptive support for those adapting to the diverse life changes associated with cancer.

Around 2,500 people every year are diagnosed with mesothelioma in the UK, an incurable cancer that affects the mesothelium, the membrane that lines the inner surface of the chest wall (pleura), the abdomen (peritoneum) or testicles. The primary cause is contact with asbestos and symptoms don’t usually appear until 20–50 years after exposure. Men are 4.6 times more likely to develop mesothelioma and with a latency period of approximately 30–40 years, the vast majority of people diagnosed with the condition are over 70 years old.

While cancer treatment can be debilitating enough in itself, one of the lesser known side-effects is the impact it has on patients’ nutrition, including reduced appetite, nausea and changes in taste. This article takes an in-depth look at the elements that community nurses need to be aware of when managing patients undergoing treatment for cancer.